Tag Archives: Sorrento Therapeutics

November, 2018

March, 2016

  • 3 March

    Sorrento Therapeutics and Yuhan Form Joint Venture Company ImmuneOncia

    SAN DIEGO and SEOUL, South Korea, March 2, 2016 /PRNewswire/ — Sorrento Therapeutics, Inc. (NASDAQ: SRNE; Sorrento), an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, and Yuhan Corporation (000100.KS; Yuhan), one of the largest and most respected pharmaceutical companies in South Korea, today announced …